These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17700195)

  • 1. Is meconium screening appropriate for universal use? Science and ethics say no.
    Marcellus L
    Adv Neonatal Care; 2007 Aug; 7(4):207-14. PubMed ID: 17700195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal screening for prenatal alcohol exposure: assessment of voluntary maternal participation in an open meconium screening program.
    Zelner I; Shor S; Lynn H; Roukema H; Lum L; Eisinga K; Koren G
    Alcohol; 2012 May; 46(3):269-76. PubMed ID: 22440689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Canadian screening tools for fetal alcohol spectrum disorder.
    Goh YI; Chudley AE; Clarren SK; Koren G; Orrbine E; Rosales T; Rosenbaum C;
    Can J Clin Pharmacol; 2008; 15(2):e344-66. PubMed ID: 18840921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal screening for prenatal alcohol exposure: a progress report of a pilot study in the region of Grey Bruce, Ontario.
    Zelner I; Shor S; Gareri J; Lynn H; Roukema H; Lum L; Eisinga K; Nulman I; Koren G
    Ther Drug Monit; 2010 Jun; 32(3):305-10. PubMed ID: 20445484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of using the Neonatal Behavioural Assessment Scale in health visiting practice.
    Girling A
    Community Pract; 2006 Apr; 79(4):118-20. PubMed ID: 16634514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening.
    Hutson JR; Rao C; Fulga N; Aleksa K; Koren G
    Alcohol; 2011 Mar; 45(2):193-9. PubMed ID: 20705417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal genetic testing is more than screening.
    Kenner C; Lewis JA; Pressler JL; Little CM
    Crit Care Nurs Clin North Am; 2008 Jun; 20(2):233-7, vii. PubMed ID: 18424352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted perinatal drug screening in a rural population.
    O'Connor TA; Bondurant HH; Siddiqui J
    J Matern Fetal Med; 1997; 6(2):108-10. PubMed ID: 9086427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine meconium screening versus drug screening per physician order: detecting the true incidence of drug-exposed infants.
    Zenewicz D; Kuhn PJ
    Pediatr Nurs; 1998; 24(6):543-6, 553. PubMed ID: 10085996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G; Hutson J; Gareri J
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting neonatal jaundice.
    Ford KL
    Community Pract; 2010 Aug; 83(8):40-2. PubMed ID: 20722332
    [No Abstract]   [Full Text] [Related]  

  • 15. Informing parents about newborn screening.
    Kemper AR; Fant KE; Clark SJ
    Public Health Nurs; 2005; 22(4):332-8. PubMed ID: 16150014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug testing in the neonate.
    Cotten SW
    Clin Lab Med; 2012 Sep; 32(3):449-66. PubMed ID: 22939302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters.
    Gareri J; Lynn H; Handley M; Rao C; Koren G
    Ther Drug Monit; 2008 Apr; 30(2):239-45. PubMed ID: 18367988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure.
    Zizzo N; Di Pietro N; Green C; Reynolds J; Bell E; Racine E
    Alcohol Clin Exp Res; 2013 Sep; 37(9):1451-5. PubMed ID: 23550996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.